drugset / Trial / NCT00755157
Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer
NaSingle-groupOpen-labelTreatment
Summary
This trial will evaluate the efficacy and safety of metronomic docetaxel and bevacizumab combination in patients with pretreated, advanced small cell lung cancer.
Timeline
- Start
- 2008-04
- Primary completion
- 2012-08
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 10 mg/kg | Intravenous |
| Subject | Docetaxel | Small molecule | 30 mg/m2 | Intravenous |